1. What Legal Standards Apply to Advertising Claims Your Corporation Makes?
Corporations must substantiate advertising claims with competent and reliable evidence before making them, and the FTC evaluates substantiation based on the type of claim, the product category, and the audience.
Express claims are straightforward factual assertions (e.g., reduces cholesterol by 10 percent). Implied claims arise from context, visuals, or omissions (e.g., showing a product in a medical setting without disclaiming endorsement). The FTC's Endorsement Guides and substantiation doctrine require that claims be truthful, not misleading, and backed by adequate testing or research before dissemination. Courts recognize that different claim types carry different burdens: health claims typically require clinical evidence, performance claims may rely on competent testing, and superiority claims invite heightened scrutiny because they invite direct competitive comparison.
How Do Federal Standards Shape Corporate Liability?
The FTC Act Section 5 prohibits unfair or deceptive practices, and Section 12 specifically targets false advertising. State consumer protection statutes often mirror or exceed federal standards. From a practitioner's perspective, the gap between what marketing teams believe about a product and what regulatory agencies will accept as substantiation is where most disputes originate. Corporations face potential liability not only for express misstatements but also for material omissions—facts a reasonable consumer would consider important in deciding whether to purchase. Courts have held that silence regarding product limitations, side effects, or comparative performance can be deceptive if the omitted information contradicts the net impression left by the advertisement.
What Role Does New York'S Attorney General Play in Advertising Oversight?
New York's Attorney General enforces the General Business Law Section 349, which prohibits deceptive practices in consumer transactions, and maintains an active advertising enforcement division. The office pursues both individual actions and coordinated multistate investigations, so corporations operating in or targeting New York consumers should expect scrutiny of claims, disclosures, and substantiation records. Documentation of testing, expert opinions, and internal decision-making regarding claim formulation becomes critical if an investigation begins; delayed or incomplete records can limit what a court can address at the summary judgment or settlement stage.
2. How Do Comparative and Superiority Claims Create Specific Legal Risk?
Comparative advertising, when truthful and substantiated, is lawful and often encouraged as pro-competitive; however, unsupported superiority claims and false comparisons invite both FTC enforcement and private litigation under the Lanham Act.
When a corporation claims its product is better, faster, or more effective than a competitor's, it must possess adequate substantiation for that superiority at the time the claim is made. The FTC does not require superiority claims to name the competitor explicitly; implied superiority (e.g., the choice of doctors) can trigger the same burden. Lanham Act Section 43(a) permits competitors to sue for false advertising, and courts apply a multifactor test: whether the claim is literally false, whether it is misleading to reasonable consumers, whether the corporation had knowledge or reckless disregard for the falsity, and whether the plaintiff has been injured. These disputes are often contested in court, and the outcome depends heavily on the substantiation evidence available and the clarity of the claim itself.
What Substantiation Standards Apply to Comparative Claims?
Comparative claims must be substantiated by the same level of evidence as non-comparative claims for the same product category. If a corporation claims its pain reliever works twice as fast, it must possess reliable clinical testing supporting that specific comparison. The FTC's Comparative Advertising Policy Statement emphasizes that comparative claims should be based on tests, studies, or other competent evidence that is reliable, valid, and representative. Vague or aspirational language (clinically proven, dermatologist recommended) without underlying data creates liability exposure, particularly in regulated categories such as health, beauty, and dietary supplements.
3. What Disclosure and Disclaimer Requirements Does Advertising Law Impose?
Material terms, limitations, and conditions must be disclosed clearly and conspicuously, and the placement, size, and prominence of disclaimers must ensure that a reasonable consumer actually notices and understands them.
The FTC's Guides on Endorsements and Testimonials, the Negative Option Rule, and industry-specific regulations all impose affirmative disclosure duties. A disclaimer buried in fine print, placed far from the relevant claim, or contradicted by dominant marketing messages is unlikely to cure an otherwise deceptive advertisement. Courts evaluate whether disclosures are clear and conspicuous by considering the overall net impression of the ad, the relative prominence of the claim versus the disclaimer, and the medium (television, print, digital, social media each present different challenges for adequate disclosure).
How Should Corporations Handle Endorsements and Testimonials?
The FTC's Endorsement Guides require that endorsers disclose material connections (payment, free products, relationships) and that testimonials reflect the typical experience of users unless the advertisement clearly states otherwise. Corporations cannot cherry-pick positive testimonials while omitting representative negative feedback if doing so creates a misleading net impression. Social media influencer campaigns, employee testimonials, and user-generated content campaigns all trigger these obligations. When an endorsement appears to be independent but the endorser has received compensation or product, the connection must be disclosed in language the audience will understand (not buried in hashtags or terms of service).
4. What Practical Steps Should Corporations Take to Manage Advertising Compliance Risk?
Corporations should establish a documented substantiation process, maintain centralized records of testing and expert opinions, implement claim review procedures before launch, and ensure that marketing, legal, and compliance teams communicate early and often.
Key considerations include conducting competitor and regulatory landscape analysis before adopting comparative claims, documenting the basis for any superiority or performance assertion, and ensuring that disclaimers are integrated into the design and placement of advertisements rather than appended as afterthoughts. For regulated product categories (health claims, environmental claims, natural or organic designations), corporations should consult with regulatory counsel and industry experts to confirm that substantiation meets or exceeds regulatory expectations. When launching campaigns in multiple states or targeting consumers across jurisdictions, corporations should account for state-specific standards; some states impose higher burdens than federal law, and coordination with advertising and marketing law counsel ensures consistency and reduces enforcement exposure. Record retention policies should preserve testing data, internal emails discussing claim formulation, and competitive analysis for at least the duration of the campaign and several years beyond, as regulatory investigations and litigation discovery often reach back multiple years.
When Should Corporations Engage Advertising Counsel?
Corporations benefit from early engagement with advertising counsel when developing new claims, entering new product categories, responding to competitor actions, or receiving regulatory inquiries. Advertising litigation exposure often arises from claims that seemed reasonable internally but fail scrutiny under regulatory or competitive standards. Counsel can help corporations evaluate whether proposed claims are supportable, whether disclaimers are adequate, and whether the overall advertisement conveys a misleading net impression. When a corporation faces a regulatory investigation or competitor lawsuit, early counsel engagement protects privilege over internal communications and allows the corporation to evaluate settlement, corrective advertising, or defense strategies from a position of informed choice rather than reactive crisis management.
28 Apr, 2026
